Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance.
Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex polygenic disease.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 7201 E Henkel Way,
- Phone
- 6026535512
- sp****@****ogy.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- systemsoncology.com
- HQ
- Scottsdale, Arizona
Systems Oncology Questions
Systems Oncology's helpline number is 6026535512
Systems Oncology's website is systemsoncology.com
Systems Oncology's LinkedIn profile is https://www.linkedin.com/company/systemsoncology
Systems Oncology has
10 employees.
View email and phone details for 10
employees at Systems Oncology.
Systems Oncology's industry is
Biotechnology Research
Systems Oncology's top competitors are
Calviri,
Oligon,
Inanobio,
Oncomyx Therapeutics,
Td2 Oncology,
Phoenix Bioscience Core,
Surgenex,
Humabiologics®, Inc,
Systems Imagination, Inc.,
Amnio Technology.
Systems Oncology's support email address is spyro@systemsoncology.com
Systems Oncology's categories are Biotechnology Research
Systems Oncology's founding year is 2015
